Striant Buccal System: 5-Year PSA Stability in Hypogonadism Treatment
Reading Time: 2 minutes Introduction The Striant testosterone buccal system has emerged as a pivotal therapeutic option for men suffering from hypogonadism, a condition characterized by low testosterone levels. As testosterone replacement therapy (TRT) gains popularity, concerns regarding its long-term effects on prostate health have intensified. Prostate-specific antigen (PSA) levels serve as a critical marker for prostate health, and any fluctuations can signal potential issues, including the risk of prostate cancer. This article delves into a prospective study that meticulously monitored PSA levels in American males over a five-year period while using the Striant system, offering valuable insights into its safety and efficacy in...


